IL6 and neoplasm: Consistently, G4 treatment greatly enhanced the production of the pro‐inflammatory factor IL‐6, IL‐12p35, and IL‐12p40 (Figure 5H), which may be attributed to the multi‐activation of DCs.[19] These results suggested that G4 treatment‐induced tumor cell recruitment and ICD, DC recruitment, and maturation might synergistically amplify the innate immune response.